Fresenius Medical Care

27 new renal dialysers have been installed in the new dialysis center. The facility meets the standards of a medical institution of such profile. The center can service up to 160 patients from Volgodonsk and the surrounding areas of the region. Fresenius has invested over 150 million rubles in this project, of which 40 million were used to purchase equipment for the dialysis center.

13 September 2018

This news was reported to the “Moscow” City New Agency by Pyotr Permyakov, the Acting Deputy Director for Investment and Innovation of the “Dubna” Special Economic Zone (SEZ). “Frerus, a resident company in the territory of the “Dubna” SEZ, plans to launch the production of artificial kidneys before the end of the year. The investor of this project is Fresenius Medical Care, a world-famous German company”, P. Permyakov said.

He explained that this plant will be the Russia’s first company to manufacture last-generation dialysis filters and artificial kidneys. Besides, the company will create 150 new jobs.

14 September 2017

The new production facility has already received a name – GAMMA

The German medical corporation Fresenius Medical Care is building a manufacturing facility to produce dialysis filters and artificial kidney machines at the Dubna Special Economic Zone in the Moscow Region, Dubna SEZ said in a press release. The new production facility has already received a name – GAMMA.

“Fresenius Medical Care (Germany) is building a manufacturing facility to produce modern dialysis equipment at the right-bank site of the Dubna Special Economic Zone. The new facility is expected to manufacture 5 million dialysis filters and 1,000 artificial kidney machines annually”, the press release said. Frerus, a representative of the German company in Russia and already a resident of the Dubna SEZ, will carry out the project.

Several years ago the German company started implementing a project in Russia to establish the Gamma production facility for manufacturing the latest-generation artificial kidney machines and dialysis filters. The location for the research and production facility has been selected at the Dubna Special Economic Zone due to its infrastructure, tax and customs advantages as well as its friendly administration system.

The Gamma product line will be distributed to Russia’s research and medical institutions as well as specialized dialysis centers. The company’s staffing needs are estimated at at least 200 highly skilled workers that the scientific research town Dubna is able to supply.

28 June 2015
Jobs: 200
Moscow region

Investor profile

Fresenius Medical Care


Company's website:

T: +49 (0) 6172 - 609 2525

Public company


Contact: Rice Powell, CEO

Fresenius Medical Care is a world leader in the organization of dialysis treatment, development and production of high-quality equipment and consumables for renal replacement therapy. The production program of the Concern includes a full range of products for the treatment of acute and chronic renal failure using the methods of hemodialysis and peritoneal dialysis.